Funding allows Stem Cell to finish merger with South Korean firm

03/17/2009 | American City Business Journals

Stem Cell Therapy International said it has secured short-term funding to finalize its merger with HistoStem, a South Korean firm that manages a cord blood and stem cell bank, to create a firm called AmStem International. Under the merger, AmStem is expected to bring to the U.S. adult stem cells from Asia for use in clinical studies and treatments.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC